Characterizing the frequency of modifiable histological changes observed on surveillance biopsies in pediatric kidney allograft recipients.

James D OdumAlexander KatsJudith Sebestyen VanSickleVimal ChadhaBrenda BrewerVincent S StaggsBradley A Warady

Published in: Pediatric nephrology (Berlin, Germany) (2020)

SBs are safe and offer the opportunity to identify and treat modifiable histologic changes in the pediatric kidney transplant population. The performance of SBs for up to 2 years after transplantation can have meaningful clinical impact.

Keyphrases

public health
kidney transplantation
stem cells
cell therapy
mesenchymal stem cells
ultrasound guided
bone marrow